Draft of Final Report of the President’s Commission on Combating Drug Addiction and the Opioid Crisis

This report discusses the final recommendations of the President’s Commission on Combating Drug Addiction and the Opioid Crisis.

Congressional Briefing - Prescription Drug Monitoring Programs (PDMPs): Critical Decision Support Tools to Respond to the Opioid Crisis - Final Agenda and Presentation

These Congressional briefing materials highlight how PDMPs are critical decision support tools to respond to the opioid crisis.

NPS and Analogues: 2017 Bill Status Update

This document provides a summary of legislation and regulation introduced during calendar year 2017 that pertains to novel psychoactive substances (“NPS”) and controlled substance analogues. The summary is divided into three categories of...

Mandated Use of State Prescription Drug Monitoring Programs (PMPs) - Highlights of Key State Requirements

This document describes the similarities and differences among state mandated PMP use provisions for prescribers. It reflects the increasing refinements by state officials who are trying to use the mandate to increase PMP use by health care...

NPS and Analogues: Summary of State Laws

This document is a product of NAMSDL’s extensive review and analysis of current state laws addressing novel psychoactive substances (“NPS”) and controlled substance analogues. On a state-by-state basis, NAMSDL lays out laws pertaining to many issues,...

Prescription Drug Monitoring Programs

Prescription Drug Monitoring Programs (PDMPs) are critical decision support tools that state officials, health care professionals, and law enforcement officers use to address opioid and   prescription drug abuse and diversion. PDMPs electronically collect, analyze and disclose specified information about prescribed controlled substances and other monitored substances dispensed to patients and their representatives. 

Novel Psychoactive Substances

Novel Psychoactive Substances (NPS), commonly referred to as synthetic drugs or designer drugs, include substances such as synthetic cannabinoids (“spice”), substituted cathinones (“bath salts”), and fentanyl analogues. NPS are manufactured by chemists to mimic the effects of other, often illegal, drugs. The resulting substances can have stronger or different effects on humans than the mimicked drug. Because many NPS are created in unregulated labs, the exact chemical composition of a particular NPS may be unknown to the user.

Drugged Driving

Drugged Driving is the act of driving a motor vehicle illegally after consuming an impairing substance other than alcohol. As with alcohol, drugged driving can occur when a driver exhibits signs of driving while under the influence or while impaired by a drug. Drugged driving may also if a driver operates a vehicle with more than a specified amount of a drug in their bloodstream, where such specified amount may be anything above zero. State laws differ substantially in the types of drugs covered by these laws, which run the gamut from substances illegal in all states (such heroin) to controlled substances whose legality varies (such as marijuana) to widely used over-the-counter substances (such as pseudoephedrine).